Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.

PI Croucher; CM Shipman; MJ Perry; J Lippitt; K Asosingh; EJR van Beek; B Van Camp; GG Russell; C Dunstan; K Vanderkerken

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.

PI Croucher, CM Shipman, MJ Perry, J Lippitt, K Asosingh, EJR van Beek, B Van Camp, GG Russell, C Dunstan, K Vanderkerken

Deanery of Clinical Sciences

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	761A-761A
Number of pages	1
Journal	Blood
Volume	96
Issue number	11
Publication status	Published - 16 Nov 2000

Cite this

@article{24dfc29d3b6547e8aff56b466c415491,

title = "Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.",

author = "PI Croucher and CM Shipman and MJ Perry and J Lippitt and K Asosingh and {van Beek}, EJR and {Van Camp}, B and GG Russell and C Dunstan and K Vanderkerken",

year = "2000",

month = nov,

day = "16",

language = "English",

volume = "96",

pages = "761A--761A",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "11",

}

TY - JOUR

T1 - Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.

AU - Croucher, PI

AU - Shipman, CM

AU - Perry, MJ

AU - Lippitt, J

AU - Asosingh, K

AU - van Beek, EJR

AU - Van Camp, B

AU - Russell, GG

AU - Dunstan, C

AU - Vanderkerken, K

PY - 2000/11/16

Y1 - 2000/11/16

M3 - Meeting abstract

VL - 96

SP - 761A-761A

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11

ER -